SubHero Banner
Text

3rd Quarter 2019

Key topics in this quarter’s edition include:

  • Brolucizumab - Treatment of wet age-related macular degeneration (AMD)
  • Ubrogepant - Acute treatment of migraine headaches
  • Luspatercept - Treatment of beta-thalassemia-associated or myelodysplastic syndromes-associated anemia
  • Cabotegravir/rilpivirine – Treatment of human immunodeficiency virus (HIV)-1 infection

Download PDF